Stimulation of chondrosarcoma cell lines with ERK, JNK, or p38 inhibitors (ERK II, SP600125, or SB203580, respectively) significantly reduced WISP-3-enhanced stimulation of VEGF-C production (Figure 2A,C, Figure 3A,C and Figure 4A,C). Here, VEGFC is linked to chondrosarcoma.